EichorEICHOR
Condition: Early Parkinson Disease Early Pd Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: Early Parkinson Disease Early Pd

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy and Safety of Entacapone Combined With Madopar in the Treatment of Early Parkinson's Disease: An Observational,
Phase N/A · 1 location(s) · Yousheng Xiao · NCT06928519Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.
Phase 1 · 1 location(s) · Pravat Mandal · NCT07064005Acupuncture and Moxibustion for Motor Symptoms in Early Parkinson's Disease
NA · 1 location(s) · Jiani Wu · NCT06874803Early Stage of Alzheimer's and Parkinson's Diseases, HearIng Relevance (SAPHIR)
NA · 4 location(s) · Cilcare SAS · NCT07083089Developing Precision Microbiota-Based Cocktail Modification Therapy to Delay the Progression of Parkinson's Disease (PD)
NA · 1 location(s) · Taipei Medical University · NCT07619560Non-Invasive Fundus Retinal Detection Technology for Early Diagnosis of Parkinson's Disease
Phase N/A · 1 location(s) · Second Affiliated Hospital, Zhejiang University, School of M · NCT07244640Exploring the Olfactory Mucosa, Blood and Urine for the Identification of Early Biomarkers of Parkinson's Disease, Atypi
Phase N/A · 3 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT06846658A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.
Phase 1 · 18 location(s) · Mission Therapeutics · NCT07630545A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Phase 3 · 319 location(s) · Merck Sharp & Dohme LLC · NCT06966700A Phase 2 Study to Assess the Effects of SUL-238 on High Energy Phosphates With ³¹P-MRS in Patients With Early, Untreate
Phase 2 · 1 location(s) · GEN İlaç ve Sağlık Ürünleri A.Ş. · NCT07322887AV133 Longitudinal Imaging Study in Patients With Early and Prdromal Parkinson's Disease
Phase N/A · 1 location(s) · Xuanwu Hospital, Beijing · NCT06456684A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's
Phase 2 · 70 location(s) · Neuron23 Inc. · NCT06680830Neuroprotective Effects of Long-term TaVNS in Early Parkinson's Disease Patients
NA · 1 location(s) · Kezhong Zhang · NCT06665113Phase IIb Clinical Trial to Evaluate the Efficacy and Safety of VG081821AC Tablets in Patients With Early to Mid-stage P
Phase 2/Phase 3 · 1 location(s) · Zhejiang Vimgreen Pharmaceuticals, Ltd. · NCT07725562First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)
Phase 1 · 2 location(s) · Regeneron Pharmaceuticals · NCT07216066Novel Shoe Device NUSHU to Measure Gait Analysis in Parkinson's Patients
NA · 1 location(s) · Weill Medical College of Cornell University · NCT06975059Clinical Study to Evaluate XS411 in Treatment of Early-onset Parkinson's Disease
Phase 1/Phase 2 · 1 location(s) · XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. · NCT07166757
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.